Skip to main content
. 2020 Aug 25:neurintsurg-2020-016671. doi: 10.1136/neurintsurg-2020-016671

Table 2.

Clinical characteristics and outcomes of patients in high and low COVID-19 counties

Thrombectomy patients in high COVID-19 burden counties (n=104) Thrombectomy patients in low COVID-19 counties (n=354) P-value*
Age, median (IQR) 70 (58–78) 72 (60–80) 0.219
Females, n (%) 46 (44.2%) 164 (46.3%) 0.706
White, n (%) 71 (68.3%) 239 (67.5%) 0.885
LKN to hospital door, median (IQR) 286 (144–639) 255 (105–490) 0.262
Admission NIHSS, median (IQR) 15 (11–20) 16 (10–21) 0.491
IV-tPA, n (%) 29 (27.9%) 155 (43.8%) 0.004
ASPECTS, median (IQR)† 9 (8–10) 8 (7–10) 0.063
Posterior circulation, n (%) 8 (7.7%) 38 (10.7%) 0.364
Intubation, n (%) 38 (36.5%) 203 (57.3%) <0.001
Door to groin, median (IQR) 68 (36–123) 85 (54–127) 0.054
LKN to groin, median (IQR) 350 (195–686) 352 (200–651) 0.529
Number of passes, median (IQR) 2 (1–3) 2 (1–3) 0.395
mTICI ≥2 b, n (%) 83 (79.8%) 298 (84.2%) 0.294
Procedure duration, median (IQR) 35 (23–62) 41 (25–69) 0.177
Door to reperfusion, median (IQR) 111 (60–188) 127 (79–176) 0.221
Length of stay, median (IQR) 5 (3–10) 6 (3–10) 0.387
DC mRS, median (IQR)‡ 4 (2–6) 4 (2–5) 0.713
Functional independence at discharge (mRS 0–2), n (%)‡ 23 (30.7%) 73 (28.7%) 0.747
sICH, n (%) 9 (8.7%) 19 (5.4%) 0.219

*Calculated using chi-square test for categorical variables and Wilcoxon test for the continuous variables.

†Only for patients with anterior circulation occlusion.

‡Missing for 130 patients.

ASPECTS, Alberta Stroke Program Early CT score; COVID-19, coronavirus disease of 2019; DC, discharge; IV-tPA, intravenous tissue plasminogen activator; LKN, last known normal; mRS, modified Rankin Scale; mTICI, modified Thrombolysis in Cerebral Infarction; NIHSS, National Institute of Health Stroke Scale; sICH, symptomatic intracerebral hematoma.

HHS Vulnerability Disclosure